Kim Chi
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 27
- Prostate Cancer Diagnosis and Treatment 5
-
- Cancer, Lipids, and Metabolism 8
- Co-authors
- Martin Edwin Gleave (12 shared papers)Amina Zoubeidi (3 shared papers)Scott K. Tyldesley (4 shared papers)Tobias Zellweger (2 shared papers)Hideaki Miyake (3 shared papers)Alan So (7 shared papers)Peter M. Venner (2 shared papers)Satoshi Kiyama (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)European Urology (3 papers)Clinical Cancer Research (3 papers)The Journal of Urology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Kim Chi
51 papers receiving 2.7k citations
Kim Chi's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 565
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 733
- Molecular Biology 923
- Radiology, Nuclear Medicine and Imaging 221
Countries citing papers authored by Kim Chi
This map shows the geographic impact of Kim Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Chi more than expected).
Fields of papers citing papers by Kim Chi
This network shows the impact of papers produced by Kim Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Chi. The network helps show where Kim Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 249 | |
| 2 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2023 | 240 |
| 3 | 2011 | 213 | |
| 4 | 2013 | 173 | |
| 5 | 2005 | 134 | |
| 6 | Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial Hit paper breakdown → | 2023 | 134 |
| 7 | Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin. | 2002 | 125 |
| 8 | 2010 | 112 | |
| 9 | 2001 | 112 | |
| 10 | 2013 | 111 | |
| 11 | A randomized phase II and pharmacokinetic study of the antisense oligonucleotides ISIS 3521 and ISIS 5132 in patients with hormone-refractory prostate cancer. | 2002 | 106 |
| 12 | 2011 | 104 | |
| 13 | 2019 | 96 | |
| 14 | 2005 | 93 | |
| 15 | 2019 | 91 | |
| 16 | 2015 | 81 | |
| 17 | 2019 | 77 | |
| 18 | 2001 | 68 | |
| 19 | 2024 | 65 | |
| 20 | 2020 | 50 |
About Kim Chi
Kim Chi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 54 papers that have together received 2.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (27 papers), Cancer, Lipids, and Metabolism (8 papers), Clusterin in disease pathology (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Hormonal and reproductive studies (5 papers), Testicular diseases and treatments (5 papers) and Nuclear Structure and Function (4 papers). The work is most often cited by research in Cancer Research (565 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (733 citations), Molecular Biology (923 citations) and Radiology, Nuclear Medicine and Imaging (221 citations). Kim Chi has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Martin Edwin Gleave, Amina Zoubeidi, Scott K. Tyldesley, Tobias Zellweger, Hideaki Miyake, Alan So, Peter M. Venner, Satoshi Kiyama, Fred Saad and Anthony W. Tolcher. Their work appears in journals such as Journal of Clinical Oncology, European Urology, Clinical Cancer Research, The Journal of Urology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.